Genotoxicity studies of tetrahydro-naphthalenebenzimidazole/ thiazolidinedione as retinoid derivatives / Tetrahidro-naftalen-benzimidazol/tiyazolidindion retinoid türevlerinin genotoksisitesi

Abstract

AbstractObjective: Mutagenicity is an undesirable side effect of clinically prescribed drugs, thus raises the question of their potential carcinogenicity. Taking into account that nitro compounds are known for their genotoxicity, it will be considerable interest to assess the genotoxic activities of the benzimidazole/thiazolidinedione retinoid derivatives. For this reason, the present study reports the genotoxicity of previously synthesized benzimidazole/ thiazolidinedione-retinoid derivatives (Ates-Alagoz and Buyukbingol, 2001; Ates-Alagoz et. al., 2009) by the umu-microplate test system.Methods: In this study, since this derivates involve nitro groups, makes advantageous the use of the umu-test, using NM2009 and NM1011 strains especially designed for detecting the mutagenicity of nitro compounds. Two bacterial strains Salmonella typhimurium NM1011 and S. typhimurium NM2009, expressing high levels of nitroreductase (NR) and O-acetyltransferase (O-AT) respectively, were used in the tests. Chlorophenol red-β-D-galactopyranoside (CPRG), O-nitrophenyl- β-D-galactopyranoside (ONPG) were used as substrate in the enzyme assays along with a well-known genotoxic nitro compound, 4-nitroquinoline 1-oxide (4NQO), as the positive control in the test.Results: Benzimidazole/ thiazolidinedione-retinoids that contain NOConclusion: None of the derivatives showed genotoxic effects, a very important data, making them a potential drug candidate.